These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 32784290)

  • 1. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
    Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
    J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Redistribution of Activated Monocyte and Dendritic Cell Subsets to the Lung Associates with Severity of COVID-19.
    Sanchez-Cerrillo I; Landete P; Aldave B; Sanchez-Alonso S; Sanchez-Azofra A; Marcos-Jimenez A; Avalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; Lopez-Sanz C; Martinez-Fleta P; Gabrie L; Del Campo Guerola L; Calzada MJ; Gonzalez-Alvaro I; Alfranca A; Sanchez-Madrid F; Munoz-Calleja C; Soriano JB; Ancochea J; Martin-Gayo E
    medRxiv; 2020 May; ():. PubMed ID: 32511573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
    Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
    Front Immunol; 2021; 12():627548. PubMed ID: 33777012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of CCR4 in activated CD8
    Spoerl S; Kremer AN; Aigner M; Eisenhauer N; Koch P; Meretuk L; Löffler P; Tenbusch M; Maier C; Überla K; Heinzerling L; Frey B; Lutzny-Geier G; Winkler TH; Krönke G; Vetter M; Bruns H; Neurath MF; Mackensen A; Kremer AE; Völkl S
    Eur J Immunol; 2021 Jun; 51(6):1436-1448. PubMed ID: 33784417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
    Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
    Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
    J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmental immunophenotyping in COVID-19 ARDS: A case series.
    Ronit A; Berg RMG; Bay JT; Haugaard AK; Ahlström MG; Burgdorf KS; Ullum H; Rørvig SB; Tjelle K; Foss NB; Benfield T; Marquart HV; Plovsing RR
    J Allergy Clin Immunol; 2021 Jan; 147(1):81-91. PubMed ID: 32979342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired function and delayed regeneration of dendritic cells in COVID-19.
    Winheim E; Rinke L; Lutz K; Reischer A; Leutbecher A; Wolfram L; Rausch L; Kranich J; Wratil PR; Huber JE; Baumjohann D; Rothenfusser S; Schubert B; Hilgendorff A; Hellmuth JC; Scherer C; Muenchhoff M; von Bergwelt-Baildon M; Stark K; Straub T; Brocker T; Keppler OT; Subklewe M; Krug AB
    PLoS Pathog; 2021 Oct; 17(10):e1009742. PubMed ID: 34614036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
    Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
    PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a
    Anft M; Paniskaki K; Blazquez-Navarro A; Doevelaar A; Seibert FS; Hölzer B; Skrzypczyk S; Kohut E; Kurek J; Zapka J; Wehler P; Kaliszczyk S; Bajda S; Thieme CJ; Roch T; Konik MJ; Berger MM; Brenner T; Kölsch U; Meister TL; Pfaender S; Steinmann E; Tempfer C; Watzl C; Dolff S; Dittmer U; Abou-El-Enein M; Westhoff TH; Witzke O; Stervbo U; Babel N
    Mol Ther; 2020 Dec; 28(12):2691-2702. PubMed ID: 33186542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
    Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
    Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Cerro Chiang G; Kassar AG; Patel N; Green CER; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
    Cell Rep; 2021 Jan; 34(1):108590. PubMed ID: 33357411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
    Jouan Y; Guillon A; Gonzalez L; Perez Y; Boisseau C; Ehrmann S; Ferreira M; Daix T; Jeannet R; François B; Dequin PF; Si-Tahar M; Baranek T; Paget C
    J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32886755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
    Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
    Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
    Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique immunological profile in patients with COVID-19.
    Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
    Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.
    Kos I; Balensiefer B; Lesan V; Kaddu-Mulindwa D; Thurner L; Christofyllakis K; Bittenbring JT; Ahlgrimm M; Seiffert M; Wagenpfeil S; Bewarder Y; Neumann F; Rixecker T; Smola S; Link A; Krawczyk M; Lammert F; Lepper PM; Bals R; Stilgenbauer S; Bewarder M
    Eur J Immunol; 2021 Jun; 51(6):1449-1460. PubMed ID: 33788264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.